InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Cagle Gerald D., Director. Director active across 1 companies, notably Aerie Pharmaceuticals INC. Aggregated, 2 reports have been logged. The latest transaction was filed on 17 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
01,750 shares0
Common Stock
SEC:0001209191-21-041979·
01,750 shares0
Common Stock
SEC:0001209191-21-041979:0·
2 of 2 declarations
About Cagle Gerald D.
Gerald D. Cagle serves as a Director at Aerie Pharmaceuticals Inc. He contributes to the strategic direction of the company by providing his expertise in the pharmaceutical field. As a director, he participates in board meetings and helps assess the company's performance and opportunities. Gerald D. Cagle is dedicated to Aerie Pharmaceuticals' mission and its sustainable growth.
